Cargando…
Inhibition of Pro-Inflammatory Cytokines by Metabolites of Streptomycetes—A Potential Alternative to Current Anti-Inflammatory Drugs?
Current treatment of chronic diseases includes, among others, application of cytokines, monoclonal antibodies, cellular therapies, and immunostimulants. As all the underlying mechanisms of a particular diseases are not always fully clarified, treatment can be inefficient and associated with various,...
Autores principales: | Hrdý, Jiří, Súkeníková, Lenka, Petrásková, Petra, Novotná, Olga, Kahoun, David, Petříček, Miroslav, Chroňáková, Alica, Petříčková, Kateřina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284804/ https://www.ncbi.nlm.nih.gov/pubmed/32344935 http://dx.doi.org/10.3390/microorganisms8050621 |
Ejemplares similares
-
A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response
por: Herbrík, Andrej, et al.
Publicado: (2020) -
Activation of a Cryptic Manumycin-Type Biosynthetic Gene Cluster of Saccharothrix espanaensis DSM44229 by Series of Genetic Manipulations
por: Gorniaková, Dominika, et al.
Publicado: (2021) -
Evolution of cyclizing 5-aminolevulinate synthases in the biosynthesis of actinomycete secondary metabolites: outcomes for genetic screening techniques
por: Petříčková, Kateřina, et al.
Publicado: (2015) -
The Impact of Escherichia coli Probiotic Strain O83:K24:H31 on the Maturation of Dendritic Cells and Immunoregulatory Functions In Vitro and In Vivo
por: Súkeníková, Lenka, et al.
Publicado: (2022) -
Polyenic Antibiotics and Other Antifungal Compounds Produced by Hemolytic Streptomyces Species
por: Bobek, Jan, et al.
Publicado: (2022)